new YORK (Reuters Health) – A survey of patients
five countries reveals that two thirds of women with cancer
breast initial want to intervene in the decisions
therapeutic.
Some want to decide on options, while
that others wish to share the decision with your doctor. Even so,
just a minority succeeds.
“Clinicians should take into account those preferences”,
it felt Richard Brown, author of the study and Professor
Wizard of Virginia Commonwealth University.
Brown team asked 683 women with cancer of
pecho newly diagnosed what role you would like to have in the
decisions on treatment. Only 28 of every 100
wanted to delegate that power to the doctor, but in 46 of each
100 cases the doctor took the decisions.
“Not surprised to see that this process was more oriented to
“”
the doctors than what the patient wanted”, said Dr.
Michael Barry, President of the Foundation for the decision of
Informadas medical decisions and that did not participate in the study.
“At times, doctors think that the majority of the
“
patients do not want to participate in the decisions, in particular
“
when comes to serious problems like cancer”, he added.
More than half of 282 women who changed their minds
after consulting the doctor wanted to participate more than the
therapeutic decisions.
A third of that group wanted originally to your doctor
take all decisions, but then chose to share it or
have the final decision. And one in five who initially
wanted to share decisions with your doctor, he preferred to have the
last word.
In Journal of Clinical Oncology, the team writes that the
women participated increasingly in the decisions on its
treatment “felt less burdened by the decision and more
“
satisfied with your final choice and communication in the
“
consulting” to patients with less participation in its
treatment.
For Barry, the results are applicable to women with
breast cancer initial because they have a lot of
effective therapeutic options. “When understood to exist
multiple treatments which can be used (…)” “manifest
most of you participate in decision making”.
After consultation with the doctor, one-third of the
participants kept the idea of the doctor controlled the
decisions. “The preference of leaving the decision to the doctor is
a perfectly reasonable decision”, felt Brown.
His team would try to conduct studies on
patients with other cancers, especially those without so many
therapeutic options available.
Source: Journal of Clinical Oncology, online February 6
2012.